Description

ROZAVEL 10 MG (1X15)

Indications

ROZAVEL 10 MG is primarily indicated for the management of hyperlipidemia, specifically for patients with elevated levels of low-density lipoprotein (LDL) cholesterol. It is often prescribed as part of a comprehensive treatment plan that includes dietary modifications and lifestyle changes. The medication may also be indicated for the prevention of cardiovascular events in individuals with a high risk of coronary artery disease.

Mechanism of Action

ROZAVEL contains the active ingredient Rosuvastatin, which belongs to the class of medications known as statins. The primary mechanism of action involves the inhibition of HMG-CoA reductase, an enzyme crucial for the biosynthesis of cholesterol in the liver. By reducing cholesterol production, ROZAVEL effectively lowers LDL cholesterol and triglyceride levels while increasing high-density lipoprotein (HDL) cholesterol. This action contributes to the stabilization of atherosclerotic plaques and the reduction of cardiovascular risks.

Pharmacological Properties

ROZAVEL exhibits a high degree of potency compared to other statins, allowing it to significantly lower LDL levels even at lower doses. The bioavailability of Rosuvastatin is approximately 20%, and its peak plasma concentration occurs within 3 to 5 hours post-administration. The drug is primarily metabolized in the liver, with a half-life of about 19 hours, allowing for once-daily dosing. It is excreted mainly via the feces, with a small percentage eliminated through urine.

Contraindications

ROZAVEL is contraindicated in patients with a known hypersensitivity to Rosuvastatin or any of the excipients in the formulation. It should not be used in individuals with active liver disease or unexplained persistent elevations in serum transaminases. Additionally, the medication is contraindicated during pregnancy and lactation due to the potential risk to the fetus or nursing infant.

Side Effects

Common side effects associated with ROZAVEL include headache, muscle pain, abdominal pain, nausea, and constipation. Serious adverse effects, although rare, may include rhabdomyolysis, liver enzyme abnormalities, and allergic reactions. Patients should be monitored for signs of muscle pain or weakness, particularly if they have a history of muscle disorders or are taking other medications that may increase the risk of myopathy.

Dosage and Administration

The recommended starting dose of ROZAVEL is typically 10 mg once daily. Depending on the individual patient’s response and tolerance, the dose may be titrated up to a maximum of 40 mg per day. It is advised to take the medication at the same time each day, with or without food. Regular monitoring of lipid levels and liver function tests is recommended to ensure efficacy and safety during treatment.

Interactions

ROZAVEL may interact with other medications, which can alter its effectiveness or increase the risk of side effects. Notable interactions include those with anticoagulants, other lipid-lowering agents, and certain medications that inhibit or induce cytochrome P450 enzymes. Patients should inform their healthcare provider of all medications, supplements, and herbal products they are taking to avoid potential interactions.

Precautions

Before initiating treatment with ROZAVEL, a thorough medical history should be taken to identify any potential risk factors for statin-related side effects. Caution should be exercised in patients with a history of liver disease, renal impairment, or those who consume excessive amounts of alcohol. Regular follow-up appointments are essential to monitor for any adverse effects and to assess the effectiveness of the therapy.

Clinical Studies

Numerous clinical studies have demonstrated the efficacy of ROZAVEL in reducing LDL cholesterol levels and improving cardiovascular outcomes. In a randomized controlled trial, patients treated with Rosuvastatin showed a significant reduction in major adverse cardiovascular events compared to those receiving placebo. The results indicated that the medication not only lowers cholesterol but also provides protective cardiovascular benefits, reinforcing its role in the management of dyslipidemia.

Conclusion

ROZAVEL 10 MG is an effective medication for managing hyperlipidemia and reducing the risk of cardiovascular events. With its potent mechanism of action and favorable pharmacological properties, it serves as a valuable option in the treatment of patients with elevated cholesterol levels. However, careful consideration of contraindications, potential side effects, and drug interactions is essential to ensure safe and effective use.